Thema: Emphysem
New drug shows promise for treating bronchiectasis
Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as a therapy for the chronic lung condition. It may soon become the first-ever FDA-approved treatment for bronchiectasis.
Surgery doesn’t always help with chronic rhinosinusitis — a new risk score predicts treatment...
A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.
Bottling a mouse ’superpower‘ may heal lungs damaged by premature birth
Using a four-dimensional microscopy technique, researchers have created 3D video images of mouse lung tissue grown in the laboratory. What they have learned has been nothing short of groundbreaking.
Stopping asthma in its tracks
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Heuschnupfen-Saison – Warum bei 7 Millionen Deutschen jetzt die Nase plötzlich läuft
Der Pollenflug ist in vollem Gange. Um die Heuschnupfen-Symptome für Allergiker so erträglich wie möglich zu gestalten, helfen einige Tipps. Welche das sind, verrät Allergologe Christoph Bergmann.Von FOCUS-online-Autorin Laura Stunz
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was not a predictor of revision surgery, according to a new study.